Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction
Clinical trial NCT06576921 · RECRUITING
Trial details
- NCT number
- NCT06576921
- Sponsor
- Xijing Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-15
- Primary completion
- 2026-05-31
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.